Harish Patel
Research Subjects
Harish Patel has a total of 141 co-authors. Here are the top co-authors by number of shared publications:
- Jasbir Makker
Gastroenterology, Bronxcare Hospital Center, Bronx, USA
12 shared publications - Haider Ghazanfar
Internal Medicine, BronxCare Health System, New York, USA
9 shared publications - Sridhar Chilimuri
Division of Gastroenterology Department of Medicine Bronx Care Health System Affiliated with Icahn School of Medicine at Mount Sinai, New York, Bronx, USA
8 shared publications - Haozhe Sun
Department of Medicine, Bronx Care Health System, Affiliated with Icahn School of Medicine at Mount Sinai, Bronx, NY, USA
7 shared publications - Kishore Kumar
Division of Gastroenterology, BronxCare Hospital Center a Clinical Affiliate of Mt Sinai Health Systems and Academic Affiliate of Icahn School of Medicine, Bronx, NY 10457, USA
7 shared publications - Danial Haris Shaikh
Division of Gastroenterology, BronxCare Health System, Icahn School of Medicine, Bronx, New York, USA
5 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (9)
Large Colonic Perineurioma Presenting During Evaluation of Chronic Abdominal Pain and Constipation
Colonic perineuriomas (PNs), also known as fibroblastic polyps, are rare benign mesenchymal lesions. They are typically found in the distal colon, particularly in the rectosigmoid region. These lesions are usually asymptomatic and incidentally detected during routine screening colonoscopy. We present a 44-year-old woman with long-standing lower abdominal pain and constipation. Colonoscopy revealed a large (5 cm), multilobulated polyp, diagnosed as a colonic PN based on histopathologic and immunohistochemical findings.
- 1 September 2026
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 13 (9)
Open AccessLarge Colonic Perineurioma Presenting During Evaluation of Chronic Abdominal Pain and Constipation
Colonic perineuriomas (PNs), also known as fibroblastic polyps, are rare benign mesenchymal lesions. They are typically found in the distal colon, particularly in the rectosigmoid region. These lesions are usually asymptomatic and incidentally detected during routine screening colonoscopy. We present a 44-year-old woman with long-standing lower abdominal pain and constipation. Colonoscopy revealed a large (5 cm), multilobulated polyp, diagnosed as a colonic PN based on histopathologic and immunohistochemical findings.
- Open Access
- 5 August 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (3) , 42
Hepatobiliary Disorders in Pregnancy: A Comprehensive Clinical Review of Gallstone Disease, Intrahepatic Cholestasis, and Viral Hepatitis
Hepatobiliary disorders during pregnancy represent a significant cause of maternal and fetal morbidity, requiring careful differentiation between physiological adaptations of pregnancy and true hepatic pathology. This narrative review provides a comprehensive overview of three major hepatobiliary conditions encountered during pregnancy: gallstone disease, intrahepatic cholestasis of pregnancy (ICP), and viral hepatitis (HAV, HBV, HCV, HDV, and HEV). Pregnancy-induced hormonal and immunological changes influence disease pathogenesis, clinical presentation, diagnostic interpretation, and therapeutic decision-making. Gallstone disease remains the most common non-obstetric surgical condition in pregnancy, with contemporary evidence supporting timely laparoscopic intervention when indicated. ICP is characterized by pruritus and elevated serum bile acids and is associated with increased risks of preterm birth, fetal distress, and stillbirth, necessitating close surveillance and individualized delivery planning. Viral hepatitis poses unique challenges because of the potential for vertical transmission, maternal complications, and adverse neonatal outcomes. Universal antenatal screening for hepatitis B and C is increasingly recognized as a cornerstone of care. For HBV, maternal antiviral prophylaxis combined with neonatal immunoprophylaxis has reduced mother-to-child transmission to below 1%, whereas the role of direct-acting antivirals for HCV during pregnancy continues to evolve. HEV remains the most severe viral hepatitis in pregnancy, carrying disproportionately high maternal mortality in endemic regions. Across all conditions, multidisciplinary management involving hepatologists, gastroenterologists, obstetricians, maternal–fetal medicine specialists, surgeons, and neonatologists is essential to optimize outcomes. This review synthesizes current evidence, highlights pregnancy-specific diagnostic and therapeutic considerations, and identifies emerging areas of research that may further improve maternal and neonatal outcomes.
- 5 August 2026
- Published by MDPI AG in Gastroenterology Insights
- Vol. 17 (3) , 42
Open AccessHepatobiliary Disorders in Pregnancy: A Comprehensive Clinical Review of Gallstone Disease, Intrahepatic Cholestasis, and Viral Hepatitis
Hepatobiliary disorders during pregnancy represent a significant cause of maternal and fetal morbidity, requiring careful differentiation between physiological adaptations of pregnancy and true hepatic pathology. This narrative review provides a comprehensive overview of three major hepatobiliary conditions encountered during pregnancy: gallstone disease, intrahepatic cholestasis of pregnancy (ICP), and viral hepatitis (HAV, HBV, HCV, HDV, and HEV). Pregnancy-induced hormonal and immunological changes influence disease pathogenesis, clinical presentation, diagnostic interpretation, and therapeutic decision-making. Gallstone disease remains the most common non-obstetric surgical condition in pregnancy, with contemporary evidence supporting timely laparoscopic intervention when indicated. ICP is characterized by pruritus and elevated serum bile acids and is associated with increased risks of preterm birth, fetal distress, and stillbirth, necessitating close surveillance and individualized delivery planning. Viral hepatitis poses unique challenges because of the potential for vertical transmission, maternal complications, and adverse neonatal outcomes. Universal antenatal screening for hepatitis B and C is increasingly recognized as a cornerstone of care. For HBV, maternal antiviral prophylaxis combined with neonatal immunoprophylaxis has reduced mother-to-child transmission to below 1%, whereas the role of direct-acting antivirals for HCV during pregnancy continues to evolve. HEV remains the most severe viral hepatitis in pregnancy, carrying disproportionately high maternal mortality in endemic regions. Across all conditions, multidisciplinary management involving hepatologists, gastroenterologists, obstetricians, maternal–fetal medicine specialists, surgeons, and neonatologists is essential to optimize outcomes. This review synthesizes current evidence, highlights pregnancy-specific diagnostic and therapeutic considerations, and identifies emerging areas of research that may further improve maternal and neonatal outcomes.
- Open Access
- 5 January 2026
- Published by MDPI AG in Preprints.org
Gastrointestinal Complications of Cocaine Use: A Comprehensive Literature Review
Background: Cocaine is the second most widely abused illicit substance worldwide and exerts potent sympathomimetic effects by inhibiting the reuptake of norepinephrine, dopamine, and serotonin. While cardiovascular and neurological complications are well recognized, gastrointestinal (GI) manifestations are increasingly reported. These arise from multifactorial mechanisms including vasospasm, endothelial dysfunction, thrombosis, ischemia, and direct mucosal toxicity, often with severe clinical consequences. Objective: This narrative review summarizes the mechanisms, pharmacokinetics, pharmacodynamics, routes of use, and spectrum of GI complications associated with cocaine exposure, with emphasis on ischemic, ulcerative, hemorrhagic, inflammatory, fibrotic, hepatobiliary, and pancreatic sequelae. Methods: We reviewed published case reports, cohort studies, and systematic reviews indexed in PubMed and major databases up to 2023. Articles focusing on pathophysiology, clinical presentation, diagnostic features, and outcomes of cocaine-induced GI disorders were included. References with available abstracts were prioritized. Results: Cocaine induces GI injury through vasoconstriction, pro-thrombotic effects, microvascular dysfunction, and direct cytotoxicity. Pharmacokinetically, cocaine demonstrates rapid absorption via intranasal, inhalational, or intravenous routes, with hepatic metabolism and elimination through benzoylecgonine and ecgonine methyl ester. Clinical gastrointestinal complications include: • Ischemic/Vascular: Mesenteric ischemia/infarction, colonic ischemia, ischemic/ hemorrhagic colitis, Vascular thrombosis • Ulcerative/Perforative: Peptic ulcer disease, Gastric, duodenal, small and large bowel perforations • Inflammatory/Fibrotic: Enteritis, enterocolitis, strictures, retroperitoneal fibrosis • Hepatobiliary & Pancreatic • Splenic • Other: GAVE, IBD mimic Rare complications such as intussusception and small bowel hematomas have also been described. Cocaine adulteration with levamisole increases risk of agranulocytosis and ischemic necrosis. Mortality is particularly high in cases of acute mesenteric ischemia, infarction, and fulminant ischemic colitis. Conclusion: Cocaine use is a significant and under-recognized contributor to severe GI morbidity and mortality. Its complications span from ischemia and perforation to hepatopancreatic injury, often requiring emergent intervention. Clinicians should maintain high suspicion for cocaine-related GI disease in young patients presenting with abdominal pain or ischemic features, as early recognition and management may improve outcomes.
- 5 January 2026
- Published by MDPI AG in Preprints.org
Open AccessGastrointestinal Complications of Cocaine Use: A Comprehensive Literature Review
Background: Cocaine is the second most widely abused illicit substance worldwide and exerts potent sympathomimetic effects by inhibiting the reuptake of norepinephrine, dopamine, and serotonin. While cardiovascular and neurological complications are well recognized, gastrointestinal (GI) manifestations are increasingly reported. These arise from multifactorial mechanisms including vasospasm, endothelial dysfunction, thrombosis, ischemia, and direct mucosal toxicity, often with severe clinical consequences. Objective: This narrative review summarizes the mechanisms, pharmacokinetics, pharmacodynamics, routes of use, and spectrum of GI complications associated with cocaine exposure, with emphasis on ischemic, ulcerative, hemorrhagic, inflammatory, fibrotic, hepatobiliary, and pancreatic sequelae. Methods: We reviewed published case reports, cohort studies, and systematic reviews indexed in PubMed and major databases up to 2023. Articles focusing on pathophysiology, clinical presentation, diagnostic features, and outcomes of cocaine-induced GI disorders were included. References with available abstracts were prioritized. Results: Cocaine induces GI injury through vasoconstriction, pro-thrombotic effects, microvascular dysfunction, and direct cytotoxicity. Pharmacokinetically, cocaine demonstrates rapid absorption via intranasal, inhalational, or intravenous routes, with hepatic metabolism and elimination through benzoylecgonine and ecgonine methyl ester. Clinical gastrointestinal complications include: • Ischemic/Vascular: Mesenteric ischemia/infarction, colonic ischemia, ischemic/ hemorrhagic colitis, Vascular thrombosis • Ulcerative/Perforative: Peptic ulcer disease, Gastric, duodenal, small and large bowel perforations • Inflammatory/Fibrotic: Enteritis, enterocolitis, strictures, retroperitoneal fibrosis • Hepatobiliary & Pancreatic • Splenic • Other: GAVE, IBD mimic Rare complications such as intussusception and small bowel hematomas have also been described. Cocaine adulteration with levamisole increases risk of agranulocytosis and ischemic necrosis. Mortality is particularly high in cases of acute mesenteric ischemia, infarction, and fulminant ischemic colitis. Conclusion: Cocaine use is a significant and under-recognized contributor to severe GI morbidity and mortality. Its complications span from ischemia and perforation to hepatopancreatic injury, often requiring emergent intervention. Clinicians should maintain high suspicion for cocaine-related GI disease in young patients presenting with abdominal pain or ischemic features, as early recognition and management may improve outcomes.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2026 (1)
Association of Biliary Source Klebsiella pneumoniae Pyogenic Liver Abscess With Colon Adenocarcinoma: A Case Report
Background: Pyogenic liver abscesses (PLAs) commonly result from hematogenous spread or biliary tract infections, most often due to cholecystitis or cholangitis. Klebsiella pneumoniae is a recognized pathogen in PLA and has been associated with underlying gastrointestinal malignancies, particularly colorectal cancer. While screening for malignancy is well established in cryptogenic K. pneumoniae liver abscess, its role when a clear biliary source is present is less well described. Case Presentation: We report a 76‐year‐old man with a history of untreated hepatitis C and prior renal cell carcinoma who presented with right upper quadrant pain, weight loss, and leukocytosis. Imaging revealed a pericholecystic liver abscess with acute cholecystitis. The abscess was drained percutaneously, and cultures grew K. pneumoniae . Although imaging suggested a biliary source, colonoscopy was performed given the pathogen’s known association with colorectal neoplasia. This revealed multiple large laterally spreading tumors, including a 30‐mm ascending colon lesion confirmed as well‐differentiated invasive adenocarcinoma on biopsy. Conclusion: This case underscores the importance of considering colorectal cancer screening in patients with K. pneumoniae PLA, even when a biliary source is identified. Early endoscopic evaluation in such patients may facilitate timely diagnosis of occult malignancy and alter clinical management.
- 1 January 2026
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2026 (1)
Open AccessAssociation of Biliary Source Klebsiella pneumoniae Pyogenic Liver Abscess With Colon Adenocarcinoma: A Case Report
Background: Pyogenic liver abscesses (PLAs) commonly result from hematogenous spread or biliary tract infections, most often due to cholecystitis or cholangitis. Klebsiella pneumoniae is a recognized pathogen in PLA and has been associated with underlying gastrointestinal malignancies, particularly colorectal cancer. While screening for malignancy is well established in cryptogenic K. pneumoniae liver abscess, its role when a clear biliary source is present is less well described. Case Presentation: We report a 76‐year‐old man with a history of untreated hepatitis C and prior renal cell carcinoma who presented with right upper quadrant pain, weight loss, and leukocytosis. Imaging revealed a pericholecystic liver abscess with acute cholecystitis. The abscess was drained percutaneously, and cultures grew K. pneumoniae . Although imaging suggested a biliary source, colonoscopy was performed given the pathogen’s known association with colorectal neoplasia. This revealed multiple large laterally spreading tumors, including a 30‐mm ascending colon lesion confirmed as well‐differentiated invasive adenocarcinoma on biopsy. Conclusion: This case underscores the importance of considering colorectal cancer screening in patients with K. pneumoniae PLA, even when a biliary source is identified. Early endoscopic evaluation in such patients may facilitate timely diagnosis of occult malignancy and alter clinical management.
- Open Access
- 29 December 2025
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 8 (1) , 3
Unrecognized Antiplatelet Effect of Mushroom Coffee: A Case of Postoperative Bleeding Following Colonic Surgery
Mushroom coffee—blends of coffee with “functional” mushroom powders—has surged in popularity, yet its hemostatic effects are poorly appreciated in perioperative care. We report a postoperative hemorrhage likely potentiated by a commercial mushroom coffee. A 62-year-old man with HIV, hepatitis C, and insulin-treated diabetes underwent colostomy reversal. On postoperative day 9, he developed brisk bleeding at the colonic anastomosis requiring angiography and embolization. Recurrent hemorrhage prompted a detailed supplement history, revealing daily use of mushroom coffee for two months preoperatively. The product’s labeled ingredients include an organic mushroom blend of cordyceps, lion’s mane (Hericium), reishi (Ganoderma), shiitake, turkey tail, and king trumpet, combined with arabica coffee, MCT oil, and coconut milk. Several constituents—reishi, cordyceps, lion’s mane, and chaga (Inonotus obliquus, used in some mushroom blends)—have published antiplatelet or antithrombotic activity in vitro and/or in vivo. After counseling, the patient discontinued mushroom coffee; no further bleeding occurred, and he recovered without additional intervention. This case highlights a clinically important but underrecognized risk: mushroom-based beverages can exert antiplatelet effects comparable to herbal supplements traditionally flagged in preoperative screening. We recommend that preoperative medication reconciliation explicitly query mushroom coffees and “adaptogenic” blends and that such products be held similarly to other agents with antiplatelet properties. Greater awareness among surgeons, anesthesiologists, and internists is needed as functional foods proliferate. Controlled studies are warranted to quantify bleeding risk from multi-mushroom products and to inform evidence-based perioperative guidance
- 29 December 2025
- Published by MDPI AG in Gastrointestinal Disorders
- Vol. 8 (1) , 3
Open AccessUnrecognized Antiplatelet Effect of Mushroom Coffee: A Case of Postoperative Bleeding Following Colonic Surgery
Mushroom coffee—blends of coffee with “functional” mushroom powders—has surged in popularity, yet its hemostatic effects are poorly appreciated in perioperative care. We report a postoperative hemorrhage likely potentiated by a commercial mushroom coffee. A 62-year-old man with HIV, hepatitis C, and insulin-treated diabetes underwent colostomy reversal. On postoperative day 9, he developed brisk bleeding at the colonic anastomosis requiring angiography and embolization. Recurrent hemorrhage prompted a detailed supplement history, revealing daily use of mushroom coffee for two months preoperatively. The product’s labeled ingredients include an organic mushroom blend of cordyceps, lion’s mane (Hericium), reishi (Ganoderma), shiitake, turkey tail, and king trumpet, combined with arabica coffee, MCT oil, and coconut milk. Several constituents—reishi, cordyceps, lion’s mane, and chaga (Inonotus obliquus, used in some mushroom blends)—have published antiplatelet or antithrombotic activity in vitro and/or in vivo. After counseling, the patient discontinued mushroom coffee; no further bleeding occurred, and he recovered without additional intervention. This case highlights a clinically important but underrecognized risk: mushroom-based beverages can exert antiplatelet effects comparable to herbal supplements traditionally flagged in preoperative screening. We recommend that preoperative medication reconciliation explicitly query mushroom coffees and “adaptogenic” blends and that such products be held similarly to other agents with antiplatelet properties. Greater awareness among surgeons, anesthesiologists, and internists is needed as functional foods proliferate. Controlled studies are warranted to quantify bleeding risk from multi-mushroom products and to inform evidence-based perioperative guidance
- Open Access
Advances in Diagnostic Modalities for Helicobacter pylori Infection
Helicobacter pylori (H. pylori) infection is a widespread global health issue with a varying prevalence influenced by geography, socioeconomic status, and demographics. In the U.S., the prevalence is lower, though certain groups, such as older adults and immigrants from high-prevalence regions, show higher rates. The decrease in infection rates in developed countries is due to improved sanitation, antibiotics, and healthcare, whereas developing countries continue to experience high rates due to poor living conditions. H. pylori infection can be asymptomatic or cause symptoms like dyspepsia, abdominal pain, bloating, nausea, and loss of appetite. Pathophysiologically, H. pylori contribute to conditions such as gastritis, peptic ulcers, and gastric cancer through mechanisms including urease production and the release of virulence factors, leading to chronic inflammation and an increased cancer risk. Diagnostic methods for H. pylori have progressed significantly. Non-invasive techniques, such as serological assays, stool antigen tests, and urea breath tests, are practical and sensitive. Invasive methods, including endoscopic biopsy and molecular diagnostics, are more definitive but resource intensive. Recent advancements in diagnostic technology, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), biosensor technology, and next-generation sequencing (NGS), promise improved speed, accuracy, and accessibility. These innovations are expected to enhance the detection and management of H. pylori, potentially reducing the global disease burden. This review aims to discuss these diagnostic modalities with a focus on further advances under investigation.
Open AccessAdvances in Diagnostic Modalities for Helicobacter pylori Infection
Helicobacter pylori (H. pylori) infection is a widespread global health issue with a varying prevalence influenced by geography, socioeconomic status, and demographics. In the U.S., the prevalence is lower, though certain groups, such as older adults and immigrants from high-prevalence regions, show higher rates. The decrease in infection rates in developed countries is due to improved sanitation, antibiotics, and healthcare, whereas developing countries continue to experience high rates due to poor living conditions. H. pylori infection can be asymptomatic or cause symptoms like dyspepsia, abdominal pain, bloating, nausea, and loss of appetite. Pathophysiologically, H. pylori contribute to conditions such as gastritis, peptic ulcers, and gastric cancer through mechanisms including urease production and the release of virulence factors, leading to chronic inflammation and an increased cancer risk. Diagnostic methods for H. pylori have progressed significantly. Non-invasive techniques, such as serological assays, stool antigen tests, and urea breath tests, are practical and sensitive. Invasive methods, including endoscopic biopsy and molecular diagnostics, are more definitive but resource intensive. Recent advancements in diagnostic technology, including matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS), biosensor technology, and next-generation sequencing (NGS), promise improved speed, accuracy, and accessibility. These innovations are expected to enhance the detection and management of H. pylori, potentially reducing the global disease burden. This review aims to discuss these diagnostic modalities with a focus on further advances under investigation.
- Open Access
Metabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
The prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing globally due to factors such as urbanization, obesity, poor nutrition, sedentary lifestyles, healthcare accessibility, diagnostic advancements, and genetic influences. Research on MAFLD and HCC risk factors, pathogenesis, and biomarkers has been conducted through a narrative review of relevant studies, with a focus on PubMed and Web of Science databases and exclusion criteria based on article availability and language. Steatosis marks the early stage of MASH advancement, commonly associated with factors of metabolic syndrome such as obesity and type 2 diabetes. Various mechanisms, including heightened lipolysis, hepatic lipogenesis, and consumption of high-calorie diets, contribute to the accumulation of lipids in the liver. Insulin resistance is pivotal in the development of steatosis, as it leads to the release of free fatty acids from adipose tissue. Natural compounds hold promise in regulating lipid metabolism and inflammation to combat these conditions. Liver fibrosis serves as a significant predictor of MASH progression and HCC development, underscoring the need to target fibrosis in treatment approaches. Risk factors for MASH-associated HCC encompass advanced liver fibrosis, older age, male gender, metabolic syndrome, genetic predispositions, and dietary habits, emphasizing the requirement for efficient surveillance and diagnostic measures. Considering these factors, it is important for further studies to determine the biochemical impact of these risk factors in order to establish targeted therapies that can prevent the development of HCC or reduce progression of MASH, indirectly decreasing the risk of HCC.
Open AccessMetabolic Dysfunction-Associated Steatohepatitis and Progression to Hepatocellular Carcinoma: A Literature Review
The prevalence of metabolic-associated fatty liver disease (MAFLD) is increasing globally due to factors such as urbanization, obesity, poor nutrition, sedentary lifestyles, healthcare accessibility, diagnostic advancements, and genetic influences. Research on MAFLD and HCC risk factors, pathogenesis, and biomarkers has been conducted through a narrative review of relevant studies, with a focus on PubMed and Web of Science databases and exclusion criteria based on article availability and language. Steatosis marks the early stage of MASH advancement, commonly associated with factors of metabolic syndrome such as obesity and type 2 diabetes. Various mechanisms, including heightened lipolysis, hepatic lipogenesis, and consumption of high-calorie diets, contribute to the accumulation of lipids in the liver. Insulin resistance is pivotal in the development of steatosis, as it leads to the release of free fatty acids from adipose tissue. Natural compounds hold promise in regulating lipid metabolism and inflammation to combat these conditions. Liver fibrosis serves as a significant predictor of MASH progression and HCC development, underscoring the need to target fibrosis in treatment approaches. Risk factors for MASH-associated HCC encompass advanced liver fibrosis, older age, male gender, metabolic syndrome, genetic predispositions, and dietary habits, emphasizing the requirement for efficient surveillance and diagnostic measures. Considering these factors, it is important for further studies to determine the biochemical impact of these risk factors in order to establish targeted therapies that can prevent the development of HCC or reduce progression of MASH, indirectly decreasing the risk of HCC.
- Open Access
- 1 January 2024
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2024 (1) , 2081040
Severe Airway Obstruction Caused by Esophageal Bezoar with Coca‐Cola and Creon (Pancrelipase) in a Patient with Underlying Achalasia: A Comprehensive Case Report
Introduction. The occurrence of acute respiratory failure as a result of esophageal bezoars is a rare phenomenon. We present a patient who failed initial endoscopic intervention. Successful resolution was achieved through a novel approach involving a combination of Creon and Coca‐Cola. Subsequently, the patient was diagnosed with achalasia, a condition that potentially contributed to the formation of the esophageal bezoar. Case Description. An 82‐year‐old man presented with respiratory distress, necessitating endotracheal intubation for airway protection. A chest computed tomogram (CT) showed pneumonia and a distended esophagus compressing the trachea, raising the possibility of an esophageal food bolus. Endoscopy revealed a severely dilated esophagus containing a significant amount of food and a phytobezoar in the lower esophagus. He failed various endoscopic techniques to remove the obstruction. Given the patient’s poor surgical candidacy, he was started in a thrice‐daily regimen of Creon dissolved in 165 mL of Coca‐Cola, over a 4‐day period. A subsequent endoscopy revealed no discernible evidence of food or bezoar. The patient was weaned from mechanical ventilation. A high‐resolution esophageal manometry identified type 1 achalasia. Conclusion. Esophageal food impaction leading to respiratory failure is rare. Endoscopy remains the mainstay approach. Surgical interventions carry significant risks. This case emphasizes the potential for noninvasive management in patients with esophageal bezoars and also underscores the significance of contemplating esophageal pathologies when addressing cases of respiratory failure. The use of Coca‐Cola and Creon emerges as a safe, effective, and cost‐efficient treatment, providing a feasible option when endoscopy proves unsuccessful before considering more aggressive interventions.
- 1 January 2024
- Published by Wiley in Case Reports in Gastrointestinal Medicine
- Vol. 2024 (1) , 2081040
Open AccessSevere Airway Obstruction Caused by Esophageal Bezoar with Coca‐Cola and Creon (Pancrelipase) in a Patient with Underlying Achalasia: A Comprehensive Case Report
Introduction. The occurrence of acute respiratory failure as a result of esophageal bezoars is a rare phenomenon. We present a patient who failed initial endoscopic intervention. Successful resolution was achieved through a novel approach involving a combination of Creon and Coca‐Cola. Subsequently, the patient was diagnosed with achalasia, a condition that potentially contributed to the formation of the esophageal bezoar. Case Description. An 82‐year‐old man presented with respiratory distress, necessitating endotracheal intubation for airway protection. A chest computed tomogram (CT) showed pneumonia and a distended esophagus compressing the trachea, raising the possibility of an esophageal food bolus. Endoscopy revealed a severely dilated esophagus containing a significant amount of food and a phytobezoar in the lower esophagus. He failed various endoscopic techniques to remove the obstruction. Given the patient’s poor surgical candidacy, he was started in a thrice‐daily regimen of Creon dissolved in 165 mL of Coca‐Cola, over a 4‐day period. A subsequent endoscopy revealed no discernible evidence of food or bezoar. The patient was weaned from mechanical ventilation. A high‐resolution esophageal manometry identified type 1 achalasia. Conclusion. Esophageal food impaction leading to respiratory failure is rare. Endoscopy remains the mainstay approach. Surgical interventions carry significant risks. This case emphasizes the potential for noninvasive management in patients with esophageal bezoars and also underscores the significance of contemplating esophageal pathologies when addressing cases of respiratory failure. The use of Coca‐Cola and Creon emerges as a safe, effective, and cost‐efficient treatment, providing a feasible option when endoscopy proves unsuccessful before considering more aggressive interventions.
- Open Access
- 25 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (21) , 3302
Associations of Real-Time Ultrasound and Strain and Shear Wave Elastography with Gastrointestinal Organs: A Systematic Review
Ultrasound elastography is gaining attention for its diagnostic potential across various medical fields, and its physical properties make it valuable in modern clinical medicine. However, its specific attributes, especially in the context of recent medical advancements, remain relatively unexplored. This study aimed to identify instrument-specific characteristics and applications of real-time ultrasound elastography, shear wave elastography, and strain elastography, particularly within gastroenterology. Following PRISMA guidelines, the study examined elastography articles on databases like PubMed, resulting in 78 included articles. Data on patient demographics, organ involvement, specificity, sensitivity, accuracy, positive predictive value, and negative predictive value were extracted. Statistical analysis involved SPSS version 21, with significance set at p < 0.05. The majority of patients were male (50.50%), with a mean age of 42.73 ± 4.41 years. Shear wave elastography was the most prevalent technique (48.7%), and liver investigations were predominant in gastroenterology (34.6%). Gastrointestinal applications showed higher sensitivity, positive predictive value, and negative predictive values (p < 0.05) but lower specificity (p < 0.05). Real-time ultrasound elastography exhibited increased specificity, accuracy, and predictive values (p < 0.05). Ultrasound elastography appears more accurate and effective in gastroenterological settings. Nonetheless, its performance depends on instrument-specific and operator-dependent factors. While promising, further studies are necessary to ascertain optimal utilization in both gastrointestinal and non-gastrointestinal conditions.
- 25 October 2023
- Published by MDPI AG in Diagnostics
- Vol. 13 (21) , 3302
Open AccessAssociations of Real-Time Ultrasound and Strain and Shear Wave Elastography with Gastrointestinal Organs: A Systematic Review
Ultrasound elastography is gaining attention for its diagnostic potential across various medical fields, and its physical properties make it valuable in modern clinical medicine. However, its specific attributes, especially in the context of recent medical advancements, remain relatively unexplored. This study aimed to identify instrument-specific characteristics and applications of real-time ultrasound elastography, shear wave elastography, and strain elastography, particularly within gastroenterology. Following PRISMA guidelines, the study examined elastography articles on databases like PubMed, resulting in 78 included articles. Data on patient demographics, organ involvement, specificity, sensitivity, accuracy, positive predictive value, and negative predictive value were extracted. Statistical analysis involved SPSS version 21, with significance set at p < 0.05. The majority of patients were male (50.50%), with a mean age of 42.73 ± 4.41 years. Shear wave elastography was the most prevalent technique (48.7%), and liver investigations were predominant in gastroenterology (34.6%). Gastrointestinal applications showed higher sensitivity, positive predictive value, and negative predictive values (p < 0.05) but lower specificity (p < 0.05). Real-time ultrasound elastography exhibited increased specificity, accuracy, and predictive values (p < 0.05). Ultrasound elastography appears more accurate and effective in gastroenterological settings. Nonetheless, its performance depends on instrument-specific and operator-dependent factors. While promising, further studies are necessary to ascertain optimal utilization in both gastrointestinal and non-gastrointestinal conditions.